<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px"><tr>
<td>Protocol#: B-20190004-01 (Amendment)</td>
<td style="text-align:right;">
<input type="checkbox" name="Compare">Compare with Original&#160;<input type="submit" name="Refresh" value="Go">
</td>
</tr></table>
<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Karine G Le Roch</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">karine.leroch@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Molecular Cell and Systems Bio</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951)827-4834</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">6/30/2008-6/30/2022</td>   <th class="THBlue">Fax</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Understanding the Life Cycle Progression of Apicomplexan Parasites.</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">UCR, NIAID, NIH, NSF, DOD</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2"></td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">Vivarium Biology&#160;&#160;&#160;</td>   <td class="TDBlue">Vivarum Biology&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Genomics Building&#160;&#160;&#160;</td>   <td class="TDBlue">2124&#160;&#160;&#160;</td>   <td class="TDBlue">Biological Safety Cabinet&#160;&#160;&#160;</td>   <td class="TDBlue">9/2/2009&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Genomics Building&#160;&#160;&#160;</td>   <td class="TDBlue">2124&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Genomics Building&#160;&#160;&#160;</td>   <td class="TDBlue">2120&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Genomics Building   &#160;&#160;&#160;</td>   <td class="TDBlue">2124&#160;&#160;&#160;</td>   <td class="TDBlue">Biological Safety Cabinet &#160;&#160;&#160;</td>   <td class="TDBlue">7/13/2015&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue"> 3213-A &#160;&#160;&#160;</td>   <td class="TDBlue">BSC&#160;&#160;&#160;</td>   <td class="TDBlue">3/4/2019&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue"> 3213-D&#160;&#160;&#160;</td>   <td class="TDBlue">BSC&#160;&#160;&#160;</td>   <td class="TDBlue">7/1/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">3209&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">3229&#160;&#160;&#160;</td>   <td class="TDBlue">Autoclave&#160;&#160;&#160;</td>   <td class="TDBlue">3/4/2019&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue"> 3213-B&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">3213-C&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">3209-G&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">20090057</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">Approved 09/26/13 -  HS-07-068</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">AUP - A-20160021Ab</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue">none</td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue">NA</td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue">NA</td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">Our Research
Our research focuses on developing biological and technological tools to dissect the molecular events driving apicomplexan parasites with a particular interest in malaria parasite life cycle progression. Using functional genomics approaches, we expect to elucidate critical regulatory networks driving the parasite life cycles and identify novel therapeutic strategies.
There are three main research projects ongoing in the laboratory

1. Revealing mechanisms controlling gene expression in the Apicomplexan parasites
Mechanisms controlling gene expression in Apicomplexan parasites are still poorly understood. Rising evidences indicate that control of gene expression in the malaria parasites occurs at multiple levels, one of those being chromatin remodeling. It is increasingly apparent that histone turnover and histone post-translational modifications are important in chromatin structure and transcriptional regulation. Determination of chromatin&#146;s structural changes will therefore be critical for the understanding of transcriptional regulation in Apicomplexan parasites including human malaria parasites . Using genome wide complementary approaches; we are investigating the parasite dynamic chromatin structure and the molecular components that regulate their features.  

2. Drug discovery and natural products
In addition to fundamental scientific approaches, we are developing drug-screening assays and high content live cell confocal imaging technologies to identify small molecule inhibitors and their morphological effects on the Apicomplexan parasites. Ongoing collaborations with several institutes are providing us with a comprehensive array of natural products. So far we have already uncovered several compounds that can inhibit malaria growth in the low nano molar ranges. Experiments to identify drug targets and drug mechanism of actions are still ongoing.

3 &#150; Detection of small interfering RNAs (siRNAs) in mosquitoes to improve surveillance of emerging mosquito borne diseases  in California.  The most recent project developed in my lab is designed to develop a new genome wide technology to detect infectious diseases  in mosquitoes. We want to detect in a genome-wide manner &#147;old and new&#148; infectious agents to prevent widespread of human disease transmitted by mosquitoes.   This innovative work is done in collaboration with Mosquito and Vector Control Districts and is funded through the CDC to the Pacific Southwest Regional Center of Excellence for Vector-Borne Disease Research at the University of California (UCR and UCD). Note that that my lab only received total RNA extracted from mosquitoes in approved facilities. We do not grow or collect mosquitoes in my lab.
</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">1- Development of new biological tools to dissect the molecular events driving Apicomplexan parasites

2- Discovery of new targets and therapeutic approaches for the treatment of Apicomplexan parasites.

3- Improve surveillance of emerging mosquito borne diseases in California.
</td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">False</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Plasmodium yoelii&#160;&#160;&#160;</td>   <td class="TDBlue">Rodents&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue"> Plasmodium berghei&#160;&#160;&#160;</td>   <td class="TDBlue">Rodents&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue"> Plasmodium chabaudi&#160;&#160;&#160;</td>   <td class="TDBlue">Rodents&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Plasmodium falciparum&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">E. Coli&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Plasmodium Vivax&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Plasmodium knowlesi&#160;&#160;&#160;</td>   <td class="TDBlue">Primate&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Babesia duncani (only extracted DNA and RNA)&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Babesia microti  (only extracted DNA and RNA) &#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Toxoplasma gondii (only extracted DNA and RNA)   &#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue">Plasmodium spp are malaria parasites infecting red blood cells.  In some case, we are genetically modifying the parasites in order to validate potential drug targets (Generation of KO) or integrate tags such as GFP or HA Tags on proteins of interest.  There is no safety issue. We are also receiving other parasite species such as Toxoplasma and Babesia for their genomic analysis.  For those parasites, our collaborators send us extracted DNA and RNAs that are not infectious. </td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">Human red blood cells are required for the culture of the human malaria parasite, P. falciparum, ex vivo.  The blood will be ordered every 2 to 3 weeks at the Interstate blood bank ( Interstate Blood Bank, Inc 5700 Pleasant View Rd, Memphis, TN 38134.  Every blood product will be handle with care and each contaminated product will be treated with 10 % bleach for at least 30 minutes
</td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Vectors including CRISPR-cas 9 vectors will be constructed to target essential genes in Plasmodium. Vector will have a drug selectable markers such as Toxoplasma goodii dihydrofolate reductase (TgDHFR&#160;&#160;&#160;</td>   <td class="TDBlue">Bacteria (E.coli), Plasmodium falciparum, human and Toxoplasma gondii    &#160;&#160;&#160;</td>   <td class="TDBlue">Species to receive DNA by electroporation are: Bacteria (E.coli) and Plasmodium falciparum.
 Type of vectors: pHHT-FCU; pHTK; pL-6 eGFP (CRISPR strategy) and pUF1-Cas9 (CRISPR strategy). 
CRISPR-cas&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">Our modifying parasite strains can be infectious. However, we growth them in our restricted culture room and followed our strict culture system procedures and disposal protocols.</td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Vertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Animal &#160;&#160;&#160;</th>   <th class="THBlue">Infectious Agent &#160;&#160;&#160;</th>   <th class="THBlue">Route(s) of Shedding/Excretion of Infectious Agents &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Mice&#160;&#160;&#160;</td>   <td class="TDBlue">Plasmodium spp.&#160;&#160;&#160;</td>   <td class="TDBlue">Blood&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using human or primate cells in animals?</th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you infecting animals with infectious agents?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">Malaria infection are species specific and any rodent malaria will NOT be able to infect human.  There is no potential environment or health hazard.</td>
</tr>
<tr>   <th class="THBlue">Do the animals shed the infectious agents?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; how long will shedding of the infectious agent occur?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using animals that have been caught in the wild?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are there potential zoonotic diseases associated with the animals?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Invertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Range of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Exotic &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Mosquitoes (Culex, Aedes, and Anopheles spp)&#160;&#160;&#160;</td>   <td class="TDBlue">Mosquitoes &#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Is the organism an arthropod?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod belong to one of the following categories: D. melanogaster, Coleoptera, Lepidoptera, cockroaches and was purchased locally or collected from local populations?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod transmit pathogens of public health importance?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; then please list which ones.</th>   <td class="TDBlue">Mosquitoes transmit infectious agents such as malaria or West Nile virus (WNV). However,  my lab only received DNA and RNA extracted from mosquitoes collected in California. Once extracted DNA or RNA cannot be infectious to anyone. </td>
</tr>
<tr>   <th class="THBlue">Is the arthropod regulated by USDA or USFWS?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please list any permits.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If the arthropod escaped would it be inviable or transient?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is there active vector borne disease cycling?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the arthropod itself genetically engineered or does it now contain an engineered virus or endosymbiont.</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod contain an engineered foreign, autonomous transposable element?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are the mobility properties of the transposable element known?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Can the transposable element spread through the species?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">
<img src="/appAsp/images/CheckBox.gif">ACL1 &#160;&#160;&#160;<img src="/appAsp/images/CheckedBox.gif">ACL2 &#160;&#160;&#160;<img src="/appAsp/images/CheckBox.gif">ACL3 &#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">Biological safety Cabinet, gloves, lab coats,</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 3/4/2019 4:33:54 PM by <b>Karine Le Roch</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckedBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Peter Atkinson</b></u></em> __________________________4/4/2019</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    </form>
</body>
</html>
